These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24098553)

  • 1. Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.
    Fujimoto K; Hayashi A; Kamata Y; Ogawa A; Watanabe T; Ichikawa R; Iso Y; Koba S; Kobayashi Y; Koyama T; Shichiri M
    PLoS One; 2013; 8(10):e76714. PubMed ID: 24098553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological fluctuations of human plasma total salusin-β, an endogenous parasympathomimetic/proatherosclerotic peptide.
    Ogawa A; Fujimoto K; Hayashi A; Chida S; Sato K; Takai K; Masaki T; Suzuki A; Kamata Y; Takano K; Koyama T; Shichiri M
    Peptides; 2014 Sep; 59():83-8. PubMed ID: 25063054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide.
    Fujimoto K; Hayashi A; Kodera Y; Saito T; Toki T; Ogawa A; Kamata Y; Takano K; Katakami H; Shichiri M
    Sci Rep; 2017 Aug; 7(1):8275. PubMed ID: 28811505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of immunoreactive salusin-beta in human plasma and urine.
    Sato K; Sato T; Susumu T; Koyama T; Shichiri M
    Regul Pept; 2009 Nov; 158(1-3):63-7. PubMed ID: 19660505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of salusins in atherosclerosis and related cardiovascular diseases.
    Watanabe T; Sato K; Itoh F; Iso Y; Nagashima M; Hirano T; Shichiri M
    J Am Soc Hypertens; 2011; 5(5):359-65. PubMed ID: 21925457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of circulating levels of salusin-α, salusin-β, and heregulin-β1 in atherosclerotic coronary arterial disease.
    Arkan A; Atukeren P; Ikitimur B; Simsek G; Koksal S; Gelisgen R; Ongen Z; Uzun H
    Clin Biochem; 2021 Jan; 87():19-25. PubMed ID: 33031820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
    Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
    Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum salusin-β levels are associated with the presence and severity of coronary artery disease.
    Liu J; Ren YG; Zhang LH; Tong YW; Kang L
    J Investig Med; 2015 Apr; 63(4):632-5. PubMed ID: 25730454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum salusin beta levels with coronary slow flow.
    Akyüz A; Aydın F; Alpsoy Ş; Ozkaramanli Gur D; Guzel S
    Anatol J Cardiol; 2019 Sep; 22(4):177-184. PubMed ID: 31584433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of salusin-beta from human monocytes/macrophages.
    Sato K; Fujimoto K; Koyama T; Shichiri M
    Regul Pept; 2010 Jun; 162(1-3):68-72. PubMed ID: 20176058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Salusin-β Levels Are Correlated with Slow Coronary Flow.
    Wang T; Dong AH; Cao HY
    Genet Test Mol Biomarkers; 2016 Jul; 20(7):393-7. PubMed ID: 27227272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of immunoreactive salusin-alpha in human serum and urine.
    Sato K; Koyama T; Tateno T; Hirata Y; Shichiri M
    Peptides; 2006 Nov; 27(11):2561-6. PubMed ID: 16889872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salusins, newly identified regulators of hemodynamics and mitogenesis, increase in polycystic ovarian syndrome.
    Celik Ö; Yılmaz E; Celik N; Minareci Y; Turkcuoglu I; Simsek Y; Celik E; Karaer A; Aydin S
    Gynecol Endocrinol; 2013 Jan; 29(1):83-6. PubMed ID: 22827297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis.
    Sipahi S; Genc AB; Acikgoz SB; Yildirim M; Aksoy YE; Vatan MB; Dheir H; Altındis M
    Singapore Med J; 2019 Apr; 60(4):210-215. PubMed ID: 30311629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum salusin-β in relation to atherosclerosis and ventricular dysfunction in patients with type 2 diabetes mellitus.
    Yassien M; Fawzy O; Mahmoud E; Khidr EG
    Diabetes Metab Syndr; 2020; 14(6):2057-2062. PubMed ID: 33113473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum salusin-α levels are inversely correlated with the presence and severity of coronary artery disease.
    Du SL; Wang WJ; Wan J; Wang YG; Wang ZK; Zhang Z
    Scand J Clin Lab Invest; 2013; 73(4):339-43. PubMed ID: 23611255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of salusin alpha and salusin beta levels in patients with newly diagnosed dipper and non-dipper hypertension.
    Alpsoy S; Dogan B; Ozkaramanli Gur D; Akyüz A; Fidan Ç; Guzel S; Ozkoyuncu B
    Clin Exp Hypertens; 2021 Jan; 43(1):42-48. PubMed ID: 32723189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct systemic distribution of salusin-α and salusin-β in the rat.
    Suzuki N; Shichiri M; Tateno T; Sato K; Hirata Y
    Peptides; 2011 Apr; 32(4):805-10. PubMed ID: 21193001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prosalusin in human neuroblastoma cells.
    Nakayama C; Shichiri M; Sato K; Hirata Y
    Peptides; 2009 Jul; 30(7):1362-7. PubMed ID: 19540434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.
    Sato K; Watanabe R; Itoh F; Shichiri M; Watanabe T
    Int J Hypertens; 2013; 2013():965140. PubMed ID: 24251033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.